Click here To download PDF Version
Tuesday
December 13 2016
7:30—11:00
Onsite Registration
9:15—11:00
Session 1: Strategic R&D Focus Area - Infectious Diseases.
Session Chairman: Dr. Yassin Arabi, Chairman, ICU, NGHA
9:15—9:30
MERS-CoV: Current knowledge and gaps
9:30—9:45
NIAID Advances in MERS and Coronavirus Research
9:45—10:00
Simian adenovirus vectored vaccines for emerging pathogens
11:00—11:45
Opening Session
Qura’an
Dr.Ahmed AlAskar KAIMRC, Executive Director KAIMRC
H.E Dr. Bandar Knawy Chief Executive Officer, MNGHA, President of King Saud bin Abdulaziz University for Health Sciences.
H.R.H. Prince Muteb Bin Abdullah Al Saud, Minister of the National Guard
Research Award Ceremony and Inventors awards
11:45—13:30
Prayer and Lunch
13:30—14:45
Session 2: Measuring the Impact of Research.
Session Chairman: Dr. Ahmed AlAskar, Executive Director, KAIMRC/NGHA
13:30—13:45
Medical R&D at MNGHA: A Strategic Look into Improving Health through Science and Making Impact
13:45—14:00
Enhancement of technological local content in health sector
14:00—14:15
Accessing Basic Human Biology and its Impact on Health Care and Industry
14:15—14:45
Panel Discussion
14:45—15:30
Tour KAIMRC Building
15:30—16:15
Tour Biobank Building
Wednesday
December 14 2016
8:45—11:45
Session 3: Contributing to the Saudi National Vision 2030: Strengthening Medical Biotechnology Development.
Session Chairman: Dr. Abdelali Haoudi, Head Strategy & Business Development, KAIMRC
8:45—9:00
Innovation in Medical R&D: a cornerstone in knowledge based economy
9:00—9:15
RVC/ Pioneering Venture Capital Investment in KSA
9:15—9:30
RPDC role in bridging the gap between laboratory research and commercial production (Transforming Innovation into Impact)
9:30—9:45
Fostering and Supporting Innovation & Technology Development Through Intellectual Property Rights
9:45—10:15
Break
10:15—10:30
Contributing to the National Vision 2030 by Leveraging Population Resources for Public Health and Economic Growth
10:30—10:45
Using Public/private partnerships to incentivize innovation in management of diseases of significant societal impact.
10:45–11:30
Panel Discussion
11:30–14:00
Lunch Break +Posters session
14:00–14:15
Diabetes in Saudi Arabia: Burden on health and Economy
14:15–14:30
Weight management of type 2 diabetes: Pharmacotherapeutic alternatives to bariatric surgery
14:30–14:45
Genomic Medicine from basic research to precision medicine: a project for Saudi Arabia
14:45–15:15
Panel Discussion
15:15–16:00
Break and Posters
16:00—17:30
Session 5: Achieving Higher Standard Publications.
Session Chairman: Dr. Abdulmajeed Abdulkareem, Vice President, Academic Affairs, KSAU-HS
16:00–16:15
Conducting and reporting health research that editors will want to publish
16:30–16:45
Towards Highly Cited Publications: KACST Role
16:45–17:00
Strategies for Identifying and Targeting Appropriate High Impact Academic Journals
Thursday
December 15 2016
8:45—09:45
Session 6: Strategic R&D Focus Area - Cardiovascular Diseases.
Session Chairman: Dr. Mouaz Al Mallah, Director, Cardiovascular Research Program, KAIMRC/NGHA
8:45–9:00
Enhancing Physical Activity, a Target for Vision 2030
9:00–9:15
Clinical Strategies for Heart Regeneration
9:15–9:30
CHD genetics : Complex but Promising field in Saudi Population
9:30–10:00
Panel Discussion
10:00–10:45
Break + Posters
10:45—12:15
Session 7: Strategic R&D Focus Area - Cancer.
Session Chairman: Dr. Sulaiman Al Ghamdi, Head, KAIMRC Western Region
10:45–11:00
Biomarker driven cancer therapy
11:00–11:15
Integrated omics for cancer therapy
11:15 –11:30
Anti-Cancer Drug Development: Potentiation using natural products
11:30–11:45
New Horizons in Cancer: Induction of Cellular Immunity for the Prevention of Relapse
11:45–12:15
Panel Discussion
12:15—13:30
Lunch Break
13:30 —15:15
Session 8: Improving Health through science: Phase 1 Clinical Trials.
Session Chairman: Dr. Farzin Farzaneh, KAIMRC/King’s College London
13:30–13:45
Medical Research from Drug Regulatory Authority Prospective
13:45–14:00
Experience with randomized controlled trials in Saudi Arabia
14:00–14:15
rapid clinical development for emerging pathogen vaccines
14:15–14:30
Improved trial designs for greater safety, higher efficacy and better value
14:30–15:15
Panel Discussion
15:15—15:45
Research Award Ceremony